Effects of melatonin in early brain injury following subarachnoid hemorrhage

被引:8
作者
Ayer, Robert E. [3 ]
Sugawara, Takashi [3 ]
Zhang, John H. [1 ,2 ,3 ]
机构
[1] Loma Linda Univ, Med Ctr, Dept Anesthesiol, Loma Linda, CA 92350 USA
[2] Loma Linda Univ, Med Ctr, Dept Neurosurg, Loma Linda, CA 92350 USA
[3] Loma Linda Univ, Med Ctr, Dept Physiol & Pharmacol, Loma Linda, CA 92350 USA
来源
INTRACRANIAL PRESSURE AND BRAIN MONITORING XIII: MECHANISMS AND TREATMENT | 2008年 / 102卷
关键词
Subarachnoid hemorrhage; Melatonin; Early brain injury; Mortality;
D O I
10.1007/978-3-211-85578-2_62
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background Aneurysmal subarachnoid hemorrhage (SAH) is a devastating disease that is associated with significant morbidity and mortality. There is substantial evidence to Suggest that oxidative stress is significant in the development of acute brain injury following SAIL Melatonin is a strong antioxidant that has low toxicity and easily passes through the BBB. Previous studies have shown that melatonin provides neuroprotection in other models of CNS injury. Methods This experiment evaluates melatonin as a neuroprotectant against early brain injury following SAH. The endovascular perforation model of SAH was performed in male Sprague Dawley rats followed by the administration of melatonin two hours after the insult. Mortality and brain water content were assessed 24 after SAH. Findings A significant reduction in 24 It mortality was seen following treatment with 150 mg/kg of melatonin. Brain water content was evaluated in the high dose treatment group to see if a reduction in brain edema was associated with reduced mortality. High dose melatonin tended to reduce brain water content following SAH. Conclusions Large doses of melatonin significantly reduced mortality and brain water content in rats following SAH.
引用
收藏
页码:327 / +
页数:3
相关论文
共 29 条
[1]   Effect of melatonin on cerebral vasospasm following experimental subarachnoid hemorrhage [J].
Aydin, MV ;
Caner, H ;
Sen, O ;
Ozen, O ;
Atalay, B ;
Cekinmez, M ;
Altinors, N .
NEUROLOGICAL RESEARCH, 2005, 27 (01) :77-82
[2]  
Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495
[3]   ACUTE PHARMACOLOGY OF MELATONIN [J].
BARCHAS, J ;
DACOSTA, F ;
SPECTOR, S .
NATURE, 1967, 214 (5091) :919-&
[4]   INITIAL AND RECURRENT BLEEDING ARE THE MAJOR CAUSES OF DEATH FOLLOWING SUBARACHNOID HEMORRHAGE [J].
BRODERICK, JP ;
BROTT, TG ;
DULDNER, JE ;
TOMSICK, T ;
LEACH, A .
STROKE, 1994, 25 (07) :1342-1347
[5]   Diffusion MR imaging during acute subarachnoid hemorrhage in rats [J].
Busch, E ;
Beaulieu, C ;
de Crespigny, A ;
Moseley, ME .
STROKE, 1998, 29 (10) :2155-2161
[6]   Preclinical evaluation of pharmacokinetics and safety of melatonin in propylene glycol for intravenous administration [J].
Cheung, Raymond Tak Fai ;
Tipoe, George L. ;
Tam, Sidney ;
Ma, Edmond Shiu Kwan ;
Zou, Liang Yu ;
Chan, Pui Shan .
JOURNAL OF PINEAL RESEARCH, 2006, 41 (04) :337-343
[7]   The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion [J].
Cheung, RTF .
JOURNAL OF PINEAL RESEARCH, 2003, 34 (03) :153-160
[8]   Global cerebral edema after subarachnoid hemorrhage - Frequency, predictors, and impact on outcome [J].
Claassen, J ;
Carhuapoma, JR ;
Kreiter, KT ;
Du, EY ;
Connolly, ES ;
Mayer, SA .
STROKE, 2002, 33 (05) :1225-1232
[10]   Oxidative stress in the human brain after subarachnoid hemorrhage [J].
Gaetani, P ;
Pasqualin, A ;
Baena, RRY ;
Borasio, E ;
Marzatico, F .
JOURNAL OF NEUROSURGERY, 1998, 89 (05) :748-754